Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a well established technology that uses a harmless virus to deliver genetic code to produce viral proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. 60-70% efficacy for both.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a well established technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. 60-70% efficacy for both.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a well established technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. 60-70% efficacy for both.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a well established technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is cheaper to make, obviously. 60-70% efficacy for both.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a well established technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is cheaper to make, obviously.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is cheaper to make, obviously.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is also tested on far more people (23k, thanks to India's large population).

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is also tested on far more people (25k, thanks to India's large population).

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is also cheaper.

India makes 60% of the world's vaccines (so probably over half the world's population is safe from the mRNA vaccine).

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...

Only rich Western countries can afford these fancy mRNA vaccines, which also require special logistics to handle.

Most developing countries will probably get them from India instead. There's two vaccines made in India: one outsourced by Oxford University and Astra Zeneca that uses viral vector tech (this is a new technology that uses a harmless virus to deliver genetic code to produce spike proteins using the body's own cells) called Covishield, and one made by India themselves which uses the old technology of inactivated (whole) coronavirus particles cultured in a lab, called Covaxin. The latter is also cheaper.

India makes 60% of the world's vaccines (so probably over half the world's population). So those of you saying these vaccines will wipe out worldwide population: not really.

In theory, the fancy new tech is better against more mutations of the virus I guess. In practice, we'll see...